Zasocitinib (TAK-279)

zasocitinib · Takeda

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Zasocitinib (TAK-279), covering 2025-04-04 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease [Phase 2]